Actively Recruiting
Ultrasound-Guided Surfactant Therapy Compared to Standard Guidelines for Premature Infants with Respiratory Distress Syndrome
Led by Connecticut Children's Medical Center · Updated on 2026-07-01
52
Participants Needed
1
Research Sites
4 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are investigating the use of point-of-care ultrasound POCUS to guide surfactant therapy in premature infants with respiratory distress syndrome RDS. This study compares a new method using lung ultrasound scores to guide surfactant treatment against the current standard guidelines. The goal is to determine if ultrasound-guided therapy leads to earlier treatment and better short-term respiratory outcomes for infants born prematurely. The trial has two groups a control group receiving surfactant based on existing unit guidelines, including a minimum oxygen requirement, and a treatment group receiving surfactant if the lung ultrasound score taken within 1-2 hours after birth is greater than 9 or if they meet the standard criteria regardless of ultrasound score. The decision to administer surfactant is thus based on real-time lung ultrasound assessment in the treatment group. Participants are premature infants with respiratory failure requiring non-invasive ventilation. Researchers will measure the oxygen saturation index at 24 hours as the primary outcome and also at 48 and 72 hours to evaluate respiratory status. The study involves random assignment to groups and excludes infants with certain congenital conditions or who have already received surfactant or intubation before ultrasound. Participation lasts through the critical early hours after birth, focusing on respiratory support and monitoring.
CONDITIONS
Brief Title
Echography-guided Surfactant THERapy (ESTHER) For Preterm Infants With Respiratory Failure
Research Team
J
Jacob Kelner
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here